Alaska healthcare worker with no history of drug allergies suffered serious 'anaphylactic-like' reaction after getting Pfizer's coronavirus vaccine


A healthcare worker in Juneau, Alaska, suffered a severe allergic reaction within 10 minutes of receiving Pfizer Inc's coronavirus vaccine on Tuesday

She remains stable in the ICU and is expected to be discharged later on Wednesday 

The woman has no known history of allergies and is said to be disappointed that she can't receive the vaccine's second dose

The anaphylactic-like reaction is believed to be the same one suffered by two British healthcare workers last week, both of whom have since recovered

It led the U.K.'s regulatory body to warn that anyone with severe allergic reactions to food or medicine not get the vaccine

In Pfizer's clinical trial, 137 people who were given the vaccine suffered allergic reactions as did 111 in the placebo group 

The controversy surrounding the covid-19 vaccine continues to mount as people’s fears are becoming justified. In a report published by Mail online on the 16th December, 2020, an Alaska healthcare worker suffered a serious allergic reaction within 10 minutes of receiving Pfizer Inc's coronavirus vaccine on Tuesday.

At a news conference on Wednesday, officials said the woman, who remains unarmed, started flushing and experiencing other signs of an allergic reaction after getting the jab at Bartlett Regional Hospital in Juneau. 

She was hospitalized and remains stable in the ICU with expectations to be discharged later today.  

The woman has no history of allergies, according to a statement from the Alaska Department of Health and Social Services.   

Dr Jay Butler, the Centers for Disease Control and Prevention's (CDC) deputy director for infectious diseases, says this is the only allergic reaction reported in the country thus far.

No national tally is available, but a crude estimate based on the few states that have begun to release their vaccination data - New York, Michigan and Idaho - would suggest that thousands of Americans have been vaccinated.

The allergic reaction is believed to be similar to the anaphylactic-like reactions suffered by two healthcare workers in Great Britain, both whom have since recovered, after they were given the Pfizer-BioNTech SE vaccine last week.

With hundreds of thousands of Americans expected to be dosed in the U.S. over the next few weeks, health officials will be on high alert to see if any other recipients experience severe reactions. 

The reaction was first reported by The New York Times on Wednesday afternoon. 

In spite of her reaction, the woman is said to be disappointed that she is unable to receive the second dose of Pfizer's vaccine. 

'She kept a very positive attitude,'  Dr Nobel Anderson, a family medicine physician at Bartlett Regional Hospital, said at the news conference.

'She was excited that she got the first dose and was disappointed that she will not be getting the second dose. And she encouraged all of us to press on.'  

Dr Anne Zink, Alaska's chief medical officer, said the state is not making any changes to its plan to administer the vaccine.

'There were over 40,000 people in the trials and we did not see any reactions like this,' Zink said.

According to Zink, one of the providers who treated the woman said of her reaction: 'Lightning is going to strike somewhere.'   

Pfizer has said anaphylactic reactions to vaccines are rare and are estimated to occur in around one per one million doses.    

'We don’t yet have all the details of the report from Alaska about a potential serious allergic reaction but are actively working with local health authorities to assess,' a Pfizer spokeswoman told

'We will closely monitor all reports suggestive of serious allergic reactions following vaccination and update labeling language if needed. 

'The prescribing information has a clear warning/precaution that appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.' 

Post a Comment